Key result
Delayed STEMI presentation beyond 2 hours linked to ~2.8-fold higher in-hospital mortality.
Why the study?
Treatment delays in STEMI patients are common, especially in developing regions like Pakistan, adversely affecting outcomes and necessitating identification of delay factors.
Does delayed presentation (>2 hours from symptom onset) increase in-hospital mortality and complications in patients with STEMI?
Cohort (n=180)
No
Does delayed presentation (>2 hours from symptom onset) increase in-hospital mortality and complications in patients with STEMI?
Absolute Event Rate: 12.2% vs 4.4%
p-value: p=<0.05
In patients with STEMI, treatment delay beyond 2 hours is strongly linked to low socioeconomic status and healthcare system inefficiencies, and it nearly triples the risk of in-hospital mortality.
Background:Coronary artery disease (CAD) is the leading cause of mortality worldwide. ST-segment elevation myocardial infarction (STEMI) requires prompt management to improve patient outcomes. Early revascularization, either through fibrinolysis or percutaneous coronary intervention (PCI), reduces myocardial ischemic time and prevents complications. However, treatment delays are common, particularly in developing regions such as Pakistan, adversely affecting patient outcomes. Identifying the factors responsible for these delays is essential.Objective:To compare clinical outcomes between STEMI patients presenting within 2 hours of symptom onset and those presenting after 2 hours.Study Design:Prospective comparative study.Duration and Place of Study:This study was conducted at People’s University of Medical and Health Sciences Nawabshahfrom February 2025 to February 2026Methodology:This prospective comparative study included 180 patients with confirmed ST-segment elevation myocardial infarction (STEMI), aged 18–65 years. Patients were enrolled through consecutive non-probability sampling after obtaining informed consent. They were divided into two groups based on time to presentation (≤2 hours vs >2 hours). Data regarding demographics, clinical characteristics, and causes of delay were collected. Statistical analysis was performed using SPSS version 25, with a p-value ≤0.05 considered statistically significant.Results:A total of 180 patients were included and equally divided into two groups. A significantly higher proportion of patients in the delayed presentation group belonged to a low socioeconomic status (Group A: 65.5% vs Group B: 20.0%). Complications were more frequent in the delayed group, including reinfarction (18.8%), in-hospital mortality (12.2%), acute heart failure (10%), and arrhythmias (12.2%).Conclusion:Delayed presentation in STEMI patients is associated with increased in-hospital mortality and a higher risk of complications. Early recognition and timely management are critical toimproving outcomes.
No takes yet. Share an insight, caveat, or question.
Dasti et al. (2026) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=180). Delayed presentation (>2 hours from symptom onset) vs. Early presentation (≤2 hours from symptom onset) was evaluated on In-hospital mortality (p=<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: